Lecture 6.2: Causality and Policy Evaluation

AREC 570 / ECON 530 · Unit 6

Lauren Chenarides

Before class

  • Athey and Imbens, “The State of Applied Econometrics: Causality and Policy Evaluation” (Athey and Imbens 2017).

Readings and course handouts are available on Canvas.

Separate the target from the tool

  • Estimand: the quantity we want to learn.
  • Estimator: the rule used to estimate it from data.
  • Estimate: the numerical result in our sample.

Example: an average treatment effect, a difference-in-means estimator, and its estimated value.

What creates a credible comparison?

For every design, ask:

  1. Who is compared with whom?
  2. What creates the difference in treatment?
  3. What must be true of the untreated counterfactual?
  4. To which population does the result apply?

Source: Athey and Imbens (2017).

Regression discontinuity

Treatment changes at a threshold in a running variable.

  • Compare observations close to the cutoff.
  • Ask whether other determinants of the outcome change smoothly.
  • Check for manipulation and other policies at the same threshold.
  • Interpret the effect locally.

Sharp and fuzzy designs

  • Sharp RD: treatment status changes deterministically at the threshold.
  • Fuzzy RD: the probability of treatment changes.

In a fuzzy design, divide the outcome discontinuity by the treatment discontinuity, with additional assumptions for a local causal interpretation.

A weak treatment discontinuity makes inference difficult.

Discussion: summer school

The source example assigns summer school using a test-score threshold.

  • Identify the running variable, cutoff, treatment, and outcome.
  • Why compare students close to the cutoff?
  • Could students or schools influence their position?
  • What would limit generalization to all students?

Difference-in-differences

τ̂=(Y‾T,post−Y‾T,pre)−(Y‾C,post−Y‾C,pre) \hat\tau = (\bar Y_{T,\mathrm{post}}-\bar Y_{T,\mathrm{pre}}) - (\bar Y_{C,\mathrm{post}}-\bar Y_{C,\mathrm{pre}})

The comparison group supplies a counterfactual change.

The key assumption concerns parallel untreated trends, not identical outcome levels.

Assess the DiD argument

  • Why should untreated trends be comparable?
  • Are there anticipatory responses?
  • Did another policy change at the same time?
  • Did group composition change?
  • Could treatment spill over to the comparison group?

Similar pre-trends are useful evidence, not proof of the identifying assumption.

Synthetic control

Construct a weighted comparison from untreated units.

  • Choose weights using pre-intervention information.
  • Assess pre-intervention fit.
  • Examine the post-intervention gap.
  • Investigate donor contamination and sensitivity.

A close pre-treatment fit does not by itself establish causality.

Discussion: choose a design

A policy begins in one region, with several years of data before and after.

  • What would support DiD?
  • What would make synthetic control attractive?
  • Would a threshold design be available?
  • Which additional institutional information do you need?

Do not select a method only because software can estimate it.

Placebos probe specific threats

A placebo asks whether the design finds an effect where the proposed mechanism predicts none.

Examples:

  • A false treatment date before the intervention.
  • An outcome that should not respond.
  • Predetermined characteristics at an RD cutoff.

Explain why each placebo is informative.

Robustness and sensitivity

Change a justified modeling or design choice and explain what that change tests.

  • Alternative bandwidth.
  • Alternative comparison group.
  • Alternative measurement.
  • Alternative functional form.

Report informative disagreements. Avoid searching for a specification that preserves a preferred result.

Discussion: the reading’s credibility checks

Choose one recommendation from Athey and Imbens.

  • Which identifying assumption does it probe?
  • What result would reduce your confidence?
  • What can the check not establish?
  • How would you report a failure?

Workshop: a credibility checklist

For your design, propose:

  1. One placebo.
  2. One sensitivity analysis.
  3. One external-validity limitation.

State the threat each item addresses.

Before you leave

Describe a result that would make you abandon or substantially revise your preferred design.

References

Athey, Susan, and Guido W. Imbens. 2017. “The State of Applied Econometrics: Causality and Policy Evaluation.” Journal of Economic Perspectives 31 (2): 3–32. https://doi.org/10.1257/jep.31.2.3.

Course navigation